License

Research Collaboration

United States – Goodwin Represents Nimbus Therapeutics In Research Collaboration And License Agreement With Lilly For Novel Oral Obesity Treatment For Up To $1.3 Billion

admin January 18, 2026 0

GP Goodwin Procter LLP More At Goodwin, we partner with our clients to practice...

Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment

admin January 11, 2026 0

-- New collaboration follows previous Lilly and Nimbus AMPK research collaboration in cardiometabolic disease -- BOSTON, January 06, 2026--(BUSINESS WIRE)--Nimbus...

ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly

admin December 31, 2025 0

- Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in...

Epitopea Announces License and Research Collaboration

admin February 20, 2025 0

MONTREAL and CAMBRIDGE, United Kingdom, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf...